News Medical on MSN1d
Self-assembling cerebral blood vessels: 3D model offers advances in Alzheimer's treatmentA 3D model accurately mimicking the blood-brain barrier (BBB) in a laboratory environment has been successfully developed by ...
A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.
Clinical diagnosis of Parkinson's disease (PD) could be performed in ... and serotoninergic systems has been implicated in the pathogenesis of depression in PD. They have been associated with ...
Understanding the pathogenesis of LID has contributed ... of dyskinesia as a motor complication in the course of Parkinson's disease (PD) includes a spectrum of involuntary movements schematically ...
HighlightsTopline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February ...
MM PD market growth will be driven by advancements in innovative therapies, including the first DMTs, and a growing patient ...
First subjects dosed in a Phase 2 trial of VTX3232 in participants with obesity and cardiometabolic risk factors, with topline data expected in H2 2025 Phase 2 trial of VTX2735 in participants with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback